These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4531056

  • 1. Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia. I. Expansion of the erythropoietin-responsive stem cell compartment.
    Ward HP, Vautrin R, Kurnick J, Robinson WA.
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):305-8. PubMed ID: 4531056
    [No Abstract] [Full Text] [Related]

  • 2. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
    Kornberg A, Fibach E, Treves A, Goldfarb A, Rachmilewitz EA.
    Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Glycosaminoglycans of human thrombocytes in normal conditions, in chronic myeloid leukosis, myelofibrosis and polycythemia vera].
    Kharchenko MF.
    Vopr Med Khim; 1973 Dec; 19(6):613-7. PubMed ID: 4277844
    [No Abstract] [Full Text] [Related]

  • 7. Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera.
    Lutton JD, Levere RD.
    Acta Haematol; 1979 Dec; 62(2):94-9. PubMed ID: 119408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum erythropoietin (ESF) levels and erythroid progenitors (CFU-Es) of patients with chronic myeloproliferative disorders.
    Fukushima Y, Miura I, Takahashi T, Fukuda M, Yoshida K, Yamaguchi A, Miura AB.
    Tohoku J Exp Med; 1984 Apr; 142(4):399-407. PubMed ID: 6588639
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The peripheral blood in polycythaemia vera and myelofibrosis.
    Leblond PF, Weed RI.
    Clin Haematol; 1975 Jun; 4(2):353-71. PubMed ID: 1102192
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D, Hasselbalch H, Knudsen JB.
    Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental and clinical megakaryocytopoiesis.
    Ebbe S.
    Clin Haematol; 1979 Jun; 8(2):371-94. PubMed ID: 158454
    [No Abstract] [Full Text] [Related]

  • 16. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract] [Full Text] [Related]

  • 17. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(2):241-51. PubMed ID: 5284903
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The spectrum of myeloproliferative disorders.
    Gilbert HS.
    Med Clin North Am; 1973 Mar 30; 57(2):355-93. PubMed ID: 4570933
    [No Abstract] [Full Text] [Related]

  • 20. Platelet defects in the myeloproliferative disorders.
    Inceman S, Tangün Y.
    Ann N Y Acad Sci; 1972 Oct 27; 201():251-61. PubMed ID: 4509685
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.